Table 3.

Specific Asthma Medication Regimens Over Follow-up by Study Group and Severity Level in 174 Children^*

	CON Group Severity†		INT Group Severity†
Asthma Medication Regimen	Mild Persistent (n = 60)	Moderate or Severe Persistent (n = 32)	Mild Persistent (n = 54)	Moderate or Severe Persistent (n = 28)	Total (N = 174)
No medication	2 (3.3)	2 (6.3)	4 (7.4)	4 (14.3)	12 (6.9)
Quick-relief medication only
Short-acting β-agonist only	7 (11.7)	3 (9.4)	11 (20.4)	6 (21.4)	27 (15.5)
Anti-inflammatory controller plus quick-relief use
Inhaled corticosteroid plus quick-relief use‡	16 (26.7)	9 (28.1)	10 (18.5)	8 (28.6)	43 (24.7)
Leukotriene modifier plus quick-relief use	2 (3.3)	0	7 (13.0)	1 (3.6)	10 (5.7)
Inhaled corticosteroid plus leukotriene modifier or mast cell stabilizer plus quick relief‡	27 (45.0)	14 (43.8)	28 (51.9)	13 (46.4)	82 (47.1)
Oral corticosteroid use
Oral corticosteroid bursts (≥1)	34 (56.7)	14 (43.8)	38 (70.4)	16 (57.1)	102 (58.6)

Abbreviations: See Table 1.

^*Data are given as number (percentage) for those who received at least 1 prescription over 12 months. Data exclude 7 children with incomplete severity data at follow-up.

^†All comparisons between groups and by severity were nonsignificant (P range, .13 to .94).

^‡For any inhaled corticosteroid use alone or in combination, there were 125 (71.8%) of 174 children.